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A Case of Lewis-Sumner Syndrome Showing Dramatic 
Improvement after Plasma Exchange
We report a patient with Lewis–Sumner syndrome (LSS) who showed an improvement only 
with plasma exchange (PE). The patient, 32-yr old man, had progressive multifocal motor-
sensory deficits with persistent, multiple conduction blocks and marked slowing of NCVs. 
Nerve pathology supported a diagnosis of demyelinating neuropathy by revealing marked 
loss of myelinated fibers with inter- and intrafascicular variation. Although the patient was 
refractory to treatment with corticosteroid and intravenous immunoglobulin, PE produced 
a dramatic improvement. Our experience strongly proposes that PE should be tried for 
refractory LSS. 
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CASE REPORT
Neuroscience
INTRODUCTION
Lewis-Sumner syndrome (LSS), first reported by Lewis et al., is 
characterized by sensorimotor deficits starting in distal upper 
limb and demyelinating mononeuropathy multiplex with per-
sistent conduction blocks involving both motor and sensory 
nerves (1). LSS has many synonyms, such as multifocal motor 
and sensory demyelinating neuropathy (MMSDN), upper limb 
predominant multifocal chronic inflammatory demyelinating 
polyneuropathy, multifocal acquired demyelinating sensory and 
motor neuropathy (MADSAM), and multifocal inflammatory 
demyelinating neuropathy (2-5). These nosologic confusions 
are produced by various views from many neurologists who have 
endeavored to differentiate the disease from chronic inflamma-
tory demyelinating polyradiculoneuropathy (CIDP) and multi-
focal motor neuropathy (MMN). Since LSS has many similari-
ties with and also some distinguishing features from CIDP and 
MMN, there is still controversy whether it is a variant of CIDP, 
an intermediate link between CIDP and MMN, or a distinct clin-
ical entity (5, 6). Although the identity of LSS is being disagreed 
on a concept, most of reports have been in agreement with the 
fact that either intravenous immune globulin (IVIg) or cortico-
steroid is the most effective in a majority of patients. Thus, these 
immunomodulating therapies are now regarded as a standard 
therapeutic modality for LSS (7-9). Although LSS is thought of a 
treatable disorder with these drugs, 10 to 20% of patients are still 
remained non-responders.
  We report a patient with chronic relapsing form of LSS, who 
was refractory to standard treatment regimens for LSS even with 
typical clinical, electrophysiological and pathologic findings, but 
showed an improvement exclusively with plasma exchange (PE). 
CASE REPORT
A 32-yr old fireman presented with tingling paresthesia in right 
fingers lasting for one month. Two months before admission, he 
had experienced muscle weakness in left fourth and fifth fingers 
and paresthesia with numbness in left palm. On admission, fol-
lowing muscle weakness was recorded: medical research coun-
cil grade 3 (G3) in left wrist flexion, finger flexion and finger fan-
ning, and G4 in left wrist extension and finger extension. Atro-
phy of small hand muscles was accompanied. Sensory system 
was abnormal revealing decreased pinprick and light touch sen-
sation in left medial palm and right third finger (Fig. 1). All deep 
tendon reflexes (DTR) were lost. Nerve conduction study (NCS) 
on first admission is summarized in Table 1 and Fig. 2; conduc-
tion block and slowing of nerve conduction velocities (NCVs) in 
right median nerve were recorded, and complete conduction 
block and no compound nerve action potential (CNAP) were 
obtained in motor and sensory conduction studies of left ulnar 
nerve, respectively. Serum antibodies against myelin compo-
nents such as GM1, GD1b, GQ1b, and MAG were all negative, 
and immunofixation and immunoelectrophoresis were unre-
markable. CSF protein was not elevated (22 mg/L, normal; 15-Park Y.-E, et al.  •  A Case of LSS Responsive to PE
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45 mg/L). Other laboratory tests excluded diagnosable periph-
eral neuropathies. Based on above results, an inflammatory de-
myelinating neuropathy was considered as a possible diagno-
sis. Therefore, intravenous methylprednisolone 1 g/day for five 
days followed by the maintenance with oral prednisolone 1 
mg/kg/day were treated. However, neither improvement nor 
further aggravation occurred.
  Third attack has come two months after the second one; he 
complained of right ankle dorsiflexion weakness, suggesting the 
affection of right deep peroneal nerve, as well as worsening of 
preceding symptoms in bilateral arms. He was again treated with 
intravenous methylprednisolone (1 g/day for 7 days) followed 
by intravenous immunoglobulin (IVIg, 0.4 g/kg/day for 5 days), 
but these symptoms were sustained without improvement. 
  Being progressively disabled in his job and daily life (e.g. driv-
ing a car) with neurologic deficits accumulated, he readmitted 
four months after the third episode. There was obvious worsen-
ing of median and ulnar nerve conduction in electrophysiologi-
cal study, as shown in Table 1. Ultrasonography, which was tried 
on median and ulnar nerves, disclosed enlarged nerve diameter 
and loss of normal lobulated pattern inside nerves, suggesting 
that there was an inflammatory response in these nerves. Oral 
Pure sensory Motor & sensory
Fig. 1. The sequential changes 
in the distributions of motor and 
sensory deficits of the patient. 
Table 1. Findings of serial nerve conduction studies
Nerve
Stimulation 
site
Recording 
site
First visit After third attack On fifth attack Six months after PE
Latency (ms)*  
or CV (m/s)
Amplitude
† Latency (ms)* 
or CV (m/s)
Amplitude
† Latency (ms)* 
or CV (m/s)
Amplitude
† Latency (ms)* 
or CV (m/s)
Amplitude
†
Motor R L R L R L R L R L R L R L R L
   Median
                    
                    
Wrist
Elbow
Axilla
APB    3.2*
45.8
34.2
   3.5*
58.1
55.5
  8.9
  2.7
  2.7
14.7
13.7
13.2
   2.8*
18.1
20.8
   3.2*
58.3
20.3
  6.8
  3.2
  1.5
12.5
  9.5
  0.7
   2.4*
13.3
11.1
-
-
-
13.6
  8.2
  1.4
NR
NR
NR
   3.0*
40.0
40.0
   3.2*
11.4
-
15.9
13.6
11.7
  8.2
  2.4
NR
   Ulnar 
               
                    
                    
Wrist
Below elbow
Above elbow
Axilla
ADM    3.0*
55.0
50.0
66.7
   3.0*
55.4
50.0
-
18.5
15.1
14.3
13.9
16.5
14.3
12.1
NR
   3.0*
59.0
60.0
66.0
-
-
-
-
13.2
11.7
11.3
11.3
NR
NR
NR
NR
   2.4*
61.1
39.2
66.7
   3.4*
14.2
14.7
39.4
  9.9
  9.3
  9.4
  9.2
  6.7
  6.7
  3.9
  0.6
   3.0*
68.8
40.0
52.0
   3.7*
-
-
-
13.8
12.2
11.3
  1.6
  8.5
NR
NR
NR
   Tibial Ankle
PF
AH   3.5
51.9
  3.5
50.0
34.4
27.2
29.5
22.4
  3.3
50.6
  3.3
53.2
25.0
17.5
20.4
12.5
  3.2
50.9
  3.6
54.7
18.5
13.6
15.5
  8.5
  3.3
51.3
  3.5
47.0
26.8
11.9
20.4
13.6
   Peroneal      
 
Ankle
Below FH
FH
EDB    3.4*
45.9
40.0
   3.3*
44.9
47.6
12.2
11.0
12.0
  9.6
  8.5
  8.4
   4.0*
45.5
55.6
   3.2*
53.8
52.4
  5.2
  0.8
  0.8
12.1
  8.5
  8.5
   5.7*
-
-
   3.2*
53.8
45.0
  0.2
NR
NR
12.1
11.3
11.0
   5.0*
68.1
38.5
   3.7*
48.6
47.8
  0.4
  0.4
  0.4
11.1
10.9
10.0
Sensory
   Median  2nd finger Wrist 44.4 46.4 16.0 28.0 50.0 46.4   7.5 23.0 43.9 40.6 10.4   5.3 50.0 46.6 12 13
   Ulnar 5th finger Wrist 45.8 39.7   9.0 14.0 45.8 -   9.0 NR 43.7 39.2   6.3   2.6 44.2 45.7   5.5   4.9
   Superficial 
      peroneal 
Lower leg Ankle 35.7 42.9 17.0 31.1 43.5 41.9 18.0 12.0 30.4 41.7   1.4 12.5 - 41.2 NR 23.0
   Sural Mid-calf Ankle 45.8 40.0 33.0 19.0 54.1 56.1 19.0 20.0 42.0 44.8 10.1 10.6 43.8 43.8 18.0 27.0
*terminal latency; 
†mV for motor nerves and μV for sensory nerves.
R, right; L, left; NR, not recordable; APB, abductor pollicis brevis; ADM, abductor digiti minimi; AH, abductor hallucis; EDB, extensor digitorum brevis; PF, popliteal fossa; FH, 
fibular head.
Fig. 2. The first nerve conduction study in right median and left ulnar nerves show 
conduction blocks and temporal dispersion with mild slowing of nerve conduction 
velocities.
Left ulnar nerve
10 mV/D
3.0 ms
55.3 m/s
50.0 m/s
3.3 ms
45.8 m/s
34.2 m/s
5 mV/D
Wrist Wrist
Elbow
Axilla
Above 
elbow
Below 
elbow
Axilla
5 ms/D 5 ms/D
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prednisolone (an initial dose of 1 mg/kg/day) was started with 
slow tapering over several months, and azathioprine (an initial 
dose of 1 mg/kg/day) was subsequently added. Despite of vari-
ous therapeutic trials, preceding symptoms were not improved. 
Furthermore, left wrist drop (fourth episode), but which was 
spontaneously recovered, and then left abducens nerve palsy 
(fifth episode) were subsequently reported with three to four 
month-intervals. 
  When he admitted with left abducens palsy as the fifth attack, 
the affection of right superficial peroneal nerve was also sus-
pected in physical examination because he newly complained 
of numbness in anterolateral aspect of right lower leg and dor-
sum of right foot. Nerve conduction study comparably reveal–
ed reduced CNAP amplitude and slowed sensory NCV in right 
superficial peroenal nerve, as well as persistent multiple con-
duction blocks and marked slowing of NCVs in median and ul-
nar nerves even though there was some improvement in these 
nerves (Table 1). This result ultimately made it possible to take 
nerve biopsy on right superficial peroneal nerve. Nerve pathol-
ogy was quite remarkable; interfascicular variation was observ–
ed, simultaneously displaying severely affected fascicles that lost 
most of myelinated fibers and relatively preserved ones (Fig. 3A). 
Semithin sections stained with toluidine blue showed promi-
nent hypertrophy of myelinated fibers and onion bulb forma-
tion, which suggests the repeated episodes of demyelination and 
remyelination (Fig. 3B). There was no evidence of either vascu-
litis or perivascular inflammation. Based on above findings of 
nerve pathology, we could ultimately confirm the diagnosis of 
LSS. 
  As the treatment with steroid, azathioprine and IVIg were not 
helpful at all, plasma exchange (hereafter PE) with exchanged 
plasma volume of 3,850 mL five times every other day, was fi-
nally tried. Surprisingly, dramatic improvement was followed; 
left abducens palsy was reversed immediately after PE, and mo-
tor and sensory deficits in left upper and right lower extremities 
were progressively recovered. Partial improvement in electro-
physiological study was also accompanied. Three months after 
PE, the patient could return back to his job only with mild dor-
siflexion weakness in right ankle and decreased sensation in 
right dorsal foot. Five months later he declared mild weakness 
and paresthesia in right hand at the visit for a regular check-up. 
The result of NCS showed aggravation in right ulnar nerve de-
spite of marked improvement in other nerves (Table 1).
  During follow-up, a few minor attacks affecting radial and fa-
cial nerves were noticed. Each episode was well controlled by 
PE scheduled as previous. 
DISCUSSION
The patient had all the typical features of chronic relapsing LSS 
in clinical and electrophysiological aspects; 1) initial neurologic 
deficits, both motor and sensory, started in upper extremities, 
and each of sequential attack was comparable to a mononeu-
ropathy multiplex, 2) electrophysiological findings also reflect-
ed a pattern of mononeuropathy multiplex throughout the stud-
ies, 3) persisitent multifocal conduction blocks, temporal dis-
persion and marked slowing of NCVs along the affected nerves 
further revealed that it is a form of demyelinating neuropathy, 
and 4) normal CSF protein level and titers of antibodies direct-
ed against myelin components (e.g. GM1 ganglioside). 
  Nerve pathology is highlighted with marked loss of myelinat-
ed nerve fibers and interfascicular variation of the lesions, which 
have been reported as a hallmark of LSS (6, 8). Although marked 
interfascicular variation is more frequently observed with isch-
emic process, nerve pathology from our patient was evidenced 
neither on vasculitis nor perivascular inflammation. As the af-
fection of right superficial peroneal nerve occurred only before 
nerve biopsy, it was unlikely that the nerve pathology was influ-
Fig. 3. Pathological findings of right superficial peroneal nerve. (A) A profound loss of myelinated fibers is seen in one fascicle, while they are relatively spared in others (modified 
Gomori-Trichome, ×40). (B) On semithin sections, marked nerve fiber hypertrophy with onion bulb formations is suggested (toluidine blue, ×400).
B APark Y.-E, et al.  •  A Case of LSS Responsive to PE
DOI: 10.3346/jkms.2010.25.7.1101 1104   http://jkms.org
enced by prior uses of steroid. Furthermore, nerve fiber hyper-
trophy and onion bulb formations as demonstrated in semithin 
sections might be another evidence of the repeated demyelin-
ation-remyelination process. Taken above findings altogether, 
what can be said for underlying pathology of the disease is – a 
demyelinating mononeuropathy multiplex. 
  Isolated abducens palsy, which was occurred as fifth episode 
and immediately resolved by PE, can also be a characteristic fea-
ture of LSS in our case. Actually, cranial nerve involvement is 
not uncommon in LSS and has been observed in 17-31% of pa-
tients from various reports. Whereas cranial nerves II, III, IV, V, 
VII, IX, and X have been described to be often involved (4, 5), 
abducens palsy has never been reported anywhere. Thus, we 
could here add abducens nerve to the list of cranial nerves which 
can be affected in LSS.
  To date, IVIg and/or corticosteroid are considered as a stan-
dard therapy for LSS. According to the literatures, therapeutic 
response rates ranged from 50 to 67% with IVIg and 25 to 79% 
with corticosteroid, and only remaining 10 to 20% of the patients 
are non-responders (8, 9). Recent study based on a large cohort 
also reported overall 73% of response rate to immune-mediated 
therapies including IVIg, steroid and azathioprine. Therefore, 
our patient was expected to show an improvement with these 
drugs. However, the patient was totally refractory to all the stan-
dard treatment as discussed before; rather, a part of preceding 
symptoms were gradually worsened, and several times of se-
quential attacks involving different nerves were followed. Final 
improvement has come only after a course of PE, and which was 
quite dramatic; left abducens palsy has immediately resolved, 
and motor and sensory deficits were subsequently recovered. 
  Most of the reports concerning LSS therapies recommend 
either IVIg or steroid as a first-line therapy, and switching one 
from the other in non-responders to either of them. Meanwhile, 
PE was rarely tried in LSS, if any, it was mostly ineffective and 
even led to an acute exacerbation during or after the treatment 
(8). Many physicians feel reluctant to use PE as a first-line ther-
apy when the expected result of PE is not much different com-
pared with other immune therapies, due to a requirement of 
closer medical attentions and a major vascular access. In addi-
tion, use of PE as a main therapy is limited since PE is only ad-
junctive and its effect is not permanent, thereby making patients 
to be dependent on the treatment (10). Nevertheless, this case 
clearly represents that PE can draw excellent outcome in a re-
fractory case to IVIg and steroid. It further means that PE can 
rescue significant population of the patients with LSS, who oth-
erwise may fall into a group of non-responders. Thus, our report 
strongly proposes that PE should be considered as an alterna-
tive therapeutic option in LSS, and physicians may be encour-
aged to try PE, particularly because LSS is among few treatable 
neuropathies. 
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